1 Min Read
Jan 19 (Reuters) - Orexigen Therapeutics Inc:
* OREXIGEN THERAPEUTICS SAYS EXPECT ANNUALIZED SAVINGS ASSOCIATED WITH FEB 2018 REDUCTION IN SALES FORCE OF ABOUT $30 MILLION - SEC FILING Source text: (bit.ly/2Bg6XUc) Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.